A clinical trial of NaV1.7 inhibitor for postoperative acute pain
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2019
Price : $35 *
At a glance
- Drugs ST-2427 (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- 10 Oct 2019 According to an SiteOne Therapeutics media release, clinical study of ST-2427 is expected to begin in 2020.
- 03 Oct 2018 New trial record
- 25 Sep 2018 According to a SiteOne Therapeutics media release, this trial is expected to start in 2019.